The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements

NCT02030990 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

300

Enrollment

FED

Sponsor class

Conditions

Corneal Opacity

Interventions

DRUG: Mitomycin-C
DRUG: Fluorometholone 1% topical ocular steroid

Sponsor

United States Naval Medical Center, San Diego